David Krenn Promoted to Vice President

Posted on March 23, 2012 by MJL

After a year with Hemosphere as Controller and Director of Operations, David Krenn has been promoted to Vice President of Finance to support company growth and infrastructure.

This entry was posted in Business News. Bookmark the permalink.

Comments are closed.

INDICATIONS FOR USE: The HeRO Graft is indicated for end stage renal disease patients on hemodialysis who have exhausted all other access options. Rx Only. See instructions for use for full indication, contraindication and caution statements. Terms and Conditions. Privacy Policy. HeRO is a Hemosphere, Inc. product distributed by CryoLife, Inc. HeRO, Hemosphere, CryoLife, ‘Life Restoring Technologies’, and the snowflake symbol are trademarks owned by CryoLife, Inc. or its subsidiaries. All other trademarks are owned by their respective companies. © 2012 CryoLife, Inc. All Rights Reserved.